FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2984883065> ?p ?o ?g. }

• W2984883065 endingPage "400" @default.
• W2984883065 startingPage "388" @default.
• W2984883065 abstract "Patients with non-small-cell lung cancer (NSCLC) containing epidermal growth factor receptor (EGFR) amplification or sensitive mutations initially respond to tyrosine kinase inhibitor gefitinib; however, the treatment is less effective over time. Gefitinib resistance mechanisms include MET gene amplification. A therapeutic strategy targeting MET as well as EGFR can overcome resistance to gefitinib. In the present study we identified Echinatin (Ecn), a characteristic chalcone in licorice, which inhibited both EGFR and MET and strongly altered NSCLC cell growth. The antitumor efficacy of Ecn against gefitinib-sensitive or –resistant NSCLC cells with EGFR mutations and MET amplification was confirmed by suppressing cell proliferation and anchorage-independent colony growth. During the targeting of EGFR and MET, Ecn significantly blocked the kinase activity, which was validated with competitive ATP binding. Inhibition of EGFR and MET by Ecn decreases the phosphorylation of downstream target proteins ERBB3, AKT and ERK compared with total protein expression or control. Ecn induced the G2/M cell cycle arrest, and apoptosis via the intrinsic pathway of caspase-dependent activation. Ecn induced ROS production and GRP78, CHOP, DR5 and DR4 expression as well as depolarized the mitochondria membrane potential. Therefore, our results suggest that Ecn is a promising therapeutic agent in NSCLC therapy." @default.
• W2984883065 created "2019-11-22" @default.
• W2984883065 creator A5001158987 @default.
• W2984883065 creator A5016743353 @default.
• W2984883065 creator A5022314272 @default.
• W2984883065 creator A5034177939 @default.
• W2984883065 creator A5042532785 @default.
• W2984883065 creator A5042621640 @default.
• W2984883065 creator A5056510525 @default.
• W2984883065 creator A5060748732 @default.
• W2984883065 creator A5066796010 @default.
• W2984883065 creator A5082336809 @default.
• W2984883065 creator A5086162691 @default.
• W2984883065 creator A5090922018 @default.
• W2984883065 date "2019-11-07" @default.
• W2984883065 modified "2023-10-02" @default.
• W2984883065 title "Dual inhibition of EGFR and MET by Echinatin retards cell growth and induces apoptosis of lung cancer cells sensitive or resistant to gefitinib" @default.
• W2984883065 cites W1031578623 @default.
• W2984883065 cites W1964231591 @default.
• W2984883065 cites W1966203663 @default.
• W2984883065 cites W1977178308 @default.
• W2984883065 cites W1997133017 @default.
• W2984883065 cites W1998971866 @default.
• W2984883065 cites W2001595708 @default.
• W2984883065 cites W2015307495 @default.
• W2984883065 cites W2020995084 @default.
• W2984883065 cites W2021505095 @default.
• W2984883065 cites W2066128027 @default.
• W2984883065 cites W2077232152 @default.
• W2984883065 cites W2087085487 @default.
• W2984883065 cites W2111109297 @default.
• W2984883065 cites W2134967712 @default.
• W2984883065 cites W2140334822 @default.
• W2984883065 cites W2150735425 @default.
• W2984883065 cites W2281422691 @default.
• W2984883065 cites W2317877264 @default.
• W2984883065 cites W2417921765 @default.
• W2984883065 cites W2498552551 @default.
• W2984883065 cites W4234236664 @default.
• W2984883065 doi "https://doi.org/10.1002/ptr.6530" @default.
• W2984883065 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31698509" @default.
• W2984883065 hasPublicationYear "2019" @default.
• W2984883065 type Work @default.
• W2984883065 sameAs 2984883065 @default.
• W2984883065 citedByCount "16" @default.
• W2984883065 countsByYear W29848830652020 @default.
• W2984883065 countsByYear W29848830652021 @default.
• W2984883065 countsByYear W29848830652022 @default.
• W2984883065 countsByYear W29848830652023 @default.
• W2984883065 crossrefType "journal-article" @default.
• W2984883065 hasAuthorship W2984883065A5001158987 @default.
• W2984883065 hasAuthorship W2984883065A5016743353 @default.
• W2984883065 hasAuthorship W2984883065A5022314272 @default.
• W2984883065 hasAuthorship W2984883065A5034177939 @default.
• W2984883065 hasAuthorship W2984883065A5042532785 @default.
• W2984883065 hasAuthorship W2984883065A5042621640 @default.
• W2984883065 hasAuthorship W2984883065A5056510525 @default.
• W2984883065 hasAuthorship W2984883065A5060748732 @default.
• W2984883065 hasAuthorship W2984883065A5066796010 @default.
• W2984883065 hasAuthorship W2984883065A5082336809 @default.
• W2984883065 hasAuthorship W2984883065A5086162691 @default.
• W2984883065 hasAuthorship W2984883065A5090922018 @default.
• W2984883065 hasConcept C115456853 @default.
• W2984883065 hasConcept C121608353 @default.
• W2984883065 hasConcept C126322002 @default.
• W2984883065 hasConcept C184235292 @default.
• W2984883065 hasConcept C190283241 @default.
• W2984883065 hasConcept C2776256026 @default.
• W2984883065 hasConcept C2777506169 @default.
• W2984883065 hasConcept C2779438470 @default.
• W2984883065 hasConcept C2779707156 @default.
• W2984883065 hasConcept C2780580887 @default.
• W2984883065 hasConcept C42362537 @default.
• W2984883065 hasConcept C502942594 @default.
• W2984883065 hasConcept C55493867 @default.
• W2984883065 hasConcept C57074206 @default.
• W2984883065 hasConcept C62112901 @default.
• W2984883065 hasConcept C62478195 @default.
• W2984883065 hasConcept C71924100 @default.
• W2984883065 hasConcept C75217442 @default.
• W2984883065 hasConcept C86803240 @default.
• W2984883065 hasConcept C95444343 @default.
• W2984883065 hasConceptScore W2984883065C115456853 @default.
• W2984883065 hasConceptScore W2984883065C121608353 @default.
• W2984883065 hasConceptScore W2984883065C126322002 @default.
• W2984883065 hasConceptScore W2984883065C184235292 @default.
• W2984883065 hasConceptScore W2984883065C190283241 @default.
• W2984883065 hasConceptScore W2984883065C2776256026 @default.
• W2984883065 hasConceptScore W2984883065C2777506169 @default.
• W2984883065 hasConceptScore W2984883065C2779438470 @default.
• W2984883065 hasConceptScore W2984883065C2779707156 @default.
• W2984883065 hasConceptScore W2984883065C2780580887 @default.
• W2984883065 hasConceptScore W2984883065C42362537 @default.
• W2984883065 hasConceptScore W2984883065C502942594 @default.
• W2984883065 hasConceptScore W2984883065C55493867 @default.
• W2984883065 hasConceptScore W2984883065C57074206 @default.
• W2984883065 hasConceptScore W2984883065C62112901 @default.
• W2984883065 hasConceptScore W2984883065C62478195 @default.

• next